Webinar: Creating cross-border value with patent term extensions and supplementary protection certificates
Dr Stephan Neuhaus
10 June 2022
The selection of a patent for Patent Term Extension (PTE) or Supplementary Protection Certification (SPC) exclusivities is a critical decision for new drug products.
Attaching that exclusivity to a patent that leaves the SPC or PTE more vulnerable to attack could result in a missed opportunity of hundreds of millions of dollars for a particular product. Recent legal developments in Europe and the U.S. have only further complicated that decision and the overall exclusivity strategy.
Our webinar addresses the differences and similarities between the different regimes and set out strategies that global companies may consider to create cross-border value in these key jurisdictions and to identify the right strategy for exclusivity in view of these legal developments.